Chemotherapy is treatment with cancer-fighting drugs.Because these medicines go into your bloodstream and can reach all parts of your body, they’re a good choice to destroy myeloma cells.

If you have tried at least four other treatments for multiple myeloma but they haven't worked or your cancer has come back, an antibody-drug conjugate might be an option. Clinical trials are underway.

These drugs are clearly very effective and have the potential of changing the way we treat multiple myeloma. Other drugs and drug regimens recently approved include ixazomib (Ninlaro), an oral ...

Multiple myeloma is treated with drug therapies, radiation therapy, ... Chemotherapy Chemo drugs destroy cancer cells, typically by preventing them from growing and dividing.

Combinations of chemotherapy drugs may work best to stop tumor growth. Prognosis and Life Expectancy Multiple myeloma usually progresses slowly, but not always.

Gail Whiteford wants to raise awareness of the symptoms she suffered to avoid the same happening to other people.

Ron Malinowski, a retired engineer living outside Ann Arbor, Michigan, was diagnosed with multiple myeloma in December 2014. He underwent a stem cell transplant in August 2015, followed by a year of ...

Blenrep is an antibody drug conjugate (ADC) that targets the BCMA protein on multiple myeloma cells, delivering to them a payload of toxic chemotherapy. There are many multiple myeloma drugs ...

Oncology is already a big piece of Pfizer’s drug lineup. The portfolio is expanding to multiple myeloma with FDA approval of Elrexfio, a bispecific antibody that targets the cancer protein BCMA.

Patients with drug-resistant multiple myeloma find early success with a new CAR T therapy, ... with the advent of chemotherapy and more advanced medicines, survival is usually four to five years.

Multiple myeloma (MM) is a type of blood cancer that is newly diagnosed in around 400 people in Ireland each year. Despite treatment advances in recent years, it remains incurable.

Multiple myeloma has long been a killer. Therapies are changing that. ... For more than 50 years, the mainstay of myeloma treatment was the chemotherapy drug melphalan and steroids.